{"id":"W2790246142","doi":"10.1093/jcag/gwy009.134","title":"A134 ANTI-IL-12/23P40 ANTIBODIES FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE","year":2018,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Cochrane; Western University","funders":"","keywords":"Ustekinumab; Medicine; Placebo; Internal medicine; Crohn's disease; Gastroenterology; Randomization; Randomized controlled trial; Immunology; Disease; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005887531,0.001026824,0.005281717,0.003853203,0.0005187676,0.001893549,0.0009923162,0.003175056,0.01178748],"category_scores_gemma":[0.01681164,0.0007928077,0.008058633,0.002497549,0.0007469036,0.001763989,0.0008632199,0.002251357,0.0008543932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001855638,"about_ca_system_score_gemma":0.001976937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002348913,"about_ca_topic_score_gemma":0.006918343,"domain_scores_codex":[0.9942513,0.002310679,0.002027598,0.0003558584,0.0009164743,0.0001382441],"domain_scores_gemma":[0.9907094,0.005471505,0.002673845,0.0001514669,0.0007721669,0.000221698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02579049,0.0003188878,0.001038883,0.8004605,0.02235996,0.0002630339,0.0001795573,0.0001852631,0.002920451,0.0005019029,0.003570535,0.1424106],"study_design_scores_gemma":[0.1364286,0.01651769,0.02695807,0.5810173,0.1616963,0.001902738,0.0003981485,0.0006257864,0.003078609,0.001497827,0.06970862,0.0001703344],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.009695034,0.985674,0.0002702399,0.0007680536,0.0005153347,0.00102655,0.0004784478,0.00002675472,0.001545745],"genre_scores_gemma":[0.1408964,0.8491213,0.002037038,0.002915633,0.000649442,0.002148557,0.0008806204,0.00001863168,0.001332406],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01178748,"threshold_uncertainty_score":0.039433,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005908803284342176,"score_gpt":0.2270294133184674,"score_spread":0.2211206100341253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}